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WHAT THIS PAPER ADDS
 This is the largest international series of infrainguinal bypass operations to be published and gives insight into variations in practice
across the globe. The paper provides information on surgery in different countries, the proportions performed for claudication and
critical ischaemia, the types of graft used, risk factors, demographics and outcomes.a r t i c l e i n f o
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Objectives: To compare practice in lower limb bypass surgery in nine countries.
Design: A prospective study amalgamating and analysing data from national and regional vascular
registries.
Methods: A table of data ﬁelds and deﬁnitions was agreed by all member countries of the Vascunet
Collaboration. Data from January 2005 to December 2009 was submitted to a central database.
Results: 32,084 cases of infrainguinal bypass (IIB) in nine countries were analysed. Procedures per
100,000 population varied between 2.3 in the UK and 24.6 in Finland. The proportion of women varied
from 25% to 43.5%. The median age for all countries was 70 for men and 76 for women. Hungary treated
the youngest patients. IIB was performed for claudication for between 15.7% and 40.8% of all procedures.
Vein grafts were used in patients operated on for claudication (52.9%), for rest pain (66.7%) and tissue
loss (74.1%). Italy had the highest use of synthetic grafts. Among claudicants 45% of bypasses were
performed to the below knee popliteal artery or more distally. Graft patency at 30 days varied between
86% and 99%.
Conclusions: Signiﬁcant variations in practice between countries were demonstrated. These results
should be interpreted alongside the known limitations of such registry data with respect to quality and
completeness of the data. Variation in data completeness and data validation between countries needs to
be improved for useful international comparison of outcomes.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.r Centre, Freeman Hospital,
7357; fax: þ44 191 223 1489.
ciety for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Infrainguinal bypass (IIB) surgery is one of the most common
procedures in vascular surgery and has been well described and
studied for decades. One might expect practice and outcomes to be
uniform throughout theworld. In the last few years themembers of
several large national vascular registries have collaborated to
compare vascular procedures at a national level through the Vas-
cunet Committee of the European Society of Vascular Surgery.
Vascunet was originally formed by a group of enthusiasts as
a working group within the European Society for Vascular Surgery
to exchange ideas and promote discussion between those
responsible for the National Registries and other interested indi-
viduals in Europe.1 Previous non-peer reviewed publications2,3
have demonstrated that amalgamation and analysis of vascular
outcome data is possible at an international level and important
geographical differences in demographic data have been high-
lighted. For this type of international comparison to be valuable
however it is necessary to ensure a common dataset so that data
comparison between countries is valid. With this in mind further
work has been undertaken since the initial publications to deﬁne
a standardised dataset across all the countries taking part in the
collaboration.
This paper presents the analysis of amalgamated data on IIB
from nine contributing countries in Europe and Australasia. Data
from over 32,000 vascular patients have been analysed making this
the largest database of its kind. In order to improve the validity of
comparisons and ensure contemporary data, we have restricted the
analysis to the last ﬁve years.Table 1
Dataset with numbers of responses for each dataﬁeld by country.
Australia Denmark Finland
Age 2384 3962 1848
Gender 2386 3962 1845
Admission date 2385 3954 1848
Admission mode 2379 3944 1710
Diabetes 2294 3935 1794
Cardiac history 0 3928 1781
Current smoker 2268 3884 1594
Pulmonary history 0 3929 1773
Cerebrovascular event history 0 3922 1776
Hypertension history 2291 3909 1787
Indication 2386 3962 1848
Side of operation 2374 3962 1824
ABI 0 2969 533
Previous ipsilateral intervention 0 3957 1847
Operation date 2386 3962 1847
Proximal anastomosis site 2243 3962 1846
Distal anastomosis site 2386 3962 1835
Graft type 2386 3962 1848
Graft type further detail 2025 2619 1074
Additional open procedure 2386 0 1847
Additional endovascular procedure 0 0 1847
Wound complication 0 3905 408
Haemorrhage 40 3900 1790
Compartment syndrome 0 3912 124
Graft patent at discharge 0 3916 1381
Graft patent at 30 days 2384 0 1845
Amputation 2384 3962 1781
Post treatment ABI 0 2358 323
Acute coronary event 186 3912 1133
Major stroke 52 3912 1135
Discharge date 2386 3917 1828
Died within 30 days of surgery 2386 3951 1778
Date of death 0 1305 85
Is post op data based on hospital
discharge or 30 days?
2386 0 1848Methods
The dataset to be collected was agreed between all the partici-
pating countries. The aims of this were to keep the dataset to
a minimum whilst providing useful comparative data, but also to
include data ﬁelds which are collected by the majority of countries
in the collaboration. It was accepted that due to the national vari-
ations in vascular data registries that not all countries would be
able to contribute data in all ﬁelds. It was agreed however that
national audit committees would be encouraged to adapt their own
datasets in the future to include the minimum international data-
set, a process that has been ongoing since 2005. Data collected was
combined data fromyears prior to the commencement of this study
and prospective data following the inception of the study up to 31st
December 2009.
The deﬁned dataset is shown in Table 1, and is available via the
Vascunet website (www.esvs.org/social/vascunet). Interventions
on existing bypasses were not included but repeat bypass grafts in
patients who had had some other previous intervention were
included.
Following deﬁnition of the dataset a data entry template was
provided to each participating country and this was used for
submission of national data to the international database. Data was
submitted for patients admitted between 1st January 2005 and 31st
December 2009.
Once the data was received from each country this was sorted
and amalgamated into a single spreadsheet for analysis. The data-
sheet was then returned to each country for error checking and
validation in order to ensure that no errors had occurred duringHungary Italy Norway Sweden Switzerland UK
1358 10,279 1445 4793 1787 4236
1363 10,279 1445 4793 1790 4235
0 10,279 1445 0 1741 4236
1363 10,279 1445 4673 0 4220
0 10,279 1445 4676 1790 3752
0 10,279 1445 4624 1790 3788
0 10,279 1445 4070 1790 3063
0 10,279 1445 4603 1790 0
0 0 1445 4580 1790 0
0 10,279 1445 4590 1790 0
1360 10,279 1445 4793 1790 3824
0 10,279 1445 4790 1719 3706
0 0 776 3521 772 1627
1363 0 1445 0 1790 3265
1363 10,279 1445 4793 1790 4203
1363 0 1445 4585 1772 3701
1362 0 1445 4625 1541 3701
1363 10,279 1445 4793 1790 4236
562 1037 0 738 1152 0
1363 0 0 1141 0 2435
1363 0 0 1141 0 0
1363 0 1445 4043 1790 2823
1363 0 1445 4043 1790 3171
0 0 1445 4044 1790 0
1342 0 1346 0 1569 0
0 0 812 4606 1569 0
1363 0 1431 4718 1790 3212
0 0 775 2830 0 0
1363 0 1445 4041 1790 3111
253 0 113 4041 1790 2786
0 0 1445 0 1747 3829
1363 10,279 1445 3687 1395 4232
0 86 28 1394 47 145
1363 0 1432 4793 1790 4236
Table 3
Number of IIB operations per year and per 100,000 population.
Catchment
area (millions)
Population
(millions)
Av. no/year no/100,000
inhab.
Australia 5.5 21.3 477 8.6
Denmark 5.5 5.5 792 14.4
Finland 1.5 5.3 369 24.6
Hungary 8 10 647 8.1
Italy Not known 60 3426
Norway 4.8 4.8 307 6.4
Sweden 9.3 9.5 959 10.3
Switzerland 5.7 7.6 447 7.8
United Kingdom 61.6 61.6 1400 2.3
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to look for data errors (e.g. an impossible date of birth), missing
data and unexpected responses and any perceived data issues were
checked back again with the referring country.
External validation of the registries
Some of the registries have performed external validation
procedures to assess the proportion of operated cases that were not
entered into the registries. The Swedvasc compared the data in the
Registry with the Inpatient Registry (IR) used for reimbursement,4
and the Population Registry, where all deaths are registered. They
were granted permission to cross-match using the personal iden-
tity code that is unique for each citizen and identiﬁes the patients in
all registries. The external validity was 93.0% regarding infrain-
guinal bypass procedures. Five hospitals (three non-participating)
accounted for 35% of the procedures missed in Swedvasc, only 5
of 33 centres registered fewer than 80% of their infrainguinal
bypass procedures. There was no statistical difference in 30 day
mortality (2.9%) between registered and unregistered patients. In
Denmark data validation has been performed and published in the
Annual Report 2010.5 The overall data completeness for index cases
(AAA, CEA, IIB) was 99.0% for the period 2001e2010. This ﬁgure is
calculated as a comparison between the Danish Vascular Registry
and the national Hospital Episodes Statistics. For IIB the rate of
missing data for wound complications was 6.8% and 7.1% for
surgical wound infection. In Australia internal validation has
demonstrated a data accuracy error rate of between 6.5% and 11.9%.
Public hospital data was externally validated using State Health
Department data and although not available in the public domain
the estimated agreement between the 2 data sources was 85%.
Private datawas externally validated usingMedicare data. In the UK
direct external validation of all IIB data was not performed.
However a comparison between Hospital Episode Statistics and
Hospital surgeon reported data for the year 2008 demonstrated
a median discrepancy between these of 3 cases per centre with an
interquartile range of 0e12.6 In Hungary, Norway, Finland,
Switzerland and Italy there was no independent external validation
performed.
Statistical analysis
Analysis of the data was done using the SPSS Program package,
version 18. Categorical variables were compared with Chi-2-test
and continuous variables with ANOVA or ManneWhitney-U test
depending on the distribution of the variable. All tests were two
tailed and level of signiﬁcance set at p < 0.01.
Results
Initial data amalgamation produced a total of 44,059 cases. This
included 22,254 cases from Italy. Following further checking of
Italian registry data it was agreed to exclude cases where a type ofTable 2
Number of IIB operations reported, per year and country.
Country
Australia Denmark Finland Hungary Italy
2005 528 919 255 0 0
2006 525 822 292 0 0
2007 433 779 437 0 3264
2008 506 693 452 796 3934
2009 394 749 411 567 3081
Total 2386 3962 1847 1363 10,279graft was not speciﬁed due to concern that some of these cases
were not open infrainguinal bypass cases. There were 10,279 cases
in Italy where a type of graft was speciﬁed. After having excluded
the other cases there were a total of 32,084 cases for analysis. There
was a wide variation in the number of cases from each country,
with Italy contributing the highest number of cases overall
(Table 2). The rate of reported IIB surgery for each country also
varied, from 2.3 per 100,000 inhabitants in the UK to 24.6 per
100,000 in Finland (Table 3). This calculation was not done for Italy
due to uncertainties regarding the precise population base.
The proportion of women undergoing infrainguinal bypass
varied from 25 % to 43.5 % (Table 4), and was higher in the Scan-
dinavian countries and Switzerland. The age at surgery shows
a more uniform picture with a median age for men of 70 and of 76
for women (Fig. 1). Hungary differs though, with a median age of 62
for men and 67 for women.
There are also differences in the indications for surgery (Fig. 2).
Bypasses for patients suffering from claudication constitute
between 15.7% and 40.8% of reported procedures for leg ischaemia.
It is notable that these extremes are found in two neighbouring
Scandinavian countries, Denmark and Norway.
Data was not available on the number of primary and secondary
bypasses, however 77.7% of cases were “primary” to the extent that
the individual had only one procedure recorded in the database.
Not all participating countries record all suggested pre-opera-
tive risk factors (Fig. 3). Diabetes was present in 21.1%e47% of cases.
Cardiac disease was found in 36.4%e58.2%, lung disease in 15.2%e
20.7%, hypertension in 51.9%e83.2% and a history of
cerebrovascular events in 9.5%e16%. All these differences
(between the highest and lowest incidence) in risk factors
between countries are highly signiﬁcant (p < 0.0001). Current
smoking was reported in 17.7%e58.4%.
The choice of vein as the conduit used for bypass differed
according to indication. The types of graft used by each country are
shown in Fig. 4 (the data on indication was not available for Italy).
Vein grafts were used increasingly with increasing degree of
ischaemia: in claudication 52.9%, in rest pain 66.7% and with tissue
loss 74.1%. The practice between countries differed however, which
is clearly shown in Fig. 5. Overall Italy had the highest use of
synthetic grafts and the lowest use of vein grafts.Total
Norway Sweden Switzerland UK
430 1212 433 321 4098
357 1081 445 334 3856
372 1015 482 525 7307
286 856 428 1408 9359
0 629 0 1633 7464
1445 4793 1788 4221 32,084
Table 4
Percentage of females among patients undergoing IIB surgery.
Proportion of females (%)
Claudication Rest pain Tissue loss All
Sweden 35.9 46.9 46.9 45.0
Finland 38.5 42.9 46.4 43.9
Denmark 38.4 46.5 40.8 41.9
Norway 33.1 38.8 42.8 37.9
Switzerland 24.7 41.4 39.9 34.9
Australia 26.5 33.6 32.6 30.7
UK 22.5 30.4 35.3 30.5
Hungary 27.2 28.3 26.5 27.4
Total 29.9 39.3 40.6 37.6
Figure 2. Indications for bypass grafting (data on indication not available from Italy).
The number of cases reported is shown with the name of each country.
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would be inﬂuenced by the degree of ischaemia. Fig. 6 shows that
this indeed was the case, with more distal bypass cases being
performed for critical limb ischaemia (CLI). It is also of note that 45%
of bypasses for claudication were performed to the below knee
popliteal artery or a more distal vessel, with 9.6% being attached to
the crural vessels. The relationship between graft type and distal
anastomosis for patients with claudication, rest pain, and tissue
loss is shown in Fig. 7.
There are considerable national differences when distal anas-
tomosis site is plotted against country for a speciﬁc indication
(Fig. 8a and b). In cases with tissue loss, the most advanced degree
of ischaemia, above knee anastomosis is used in between 8.7% and
39% of cases.
Post-operative complications are reported in Table 5 for in
hospital stay for Australia, Hungary, Denmark, UK, and Switzerland,
and up to 30 days for Sweden, Finland and Norway.
The reported graft patency varies according to graft material but
differences are small during the short term follow-up available in
the present data (Table 6). The degree of ischaemia seems to
inﬂuence patency more than graft material.
Graft patency was reported by seven countries, this was at the
time of discharge by six and at 30 days by one other, and at both by
two (Table 7). One-year follow-up data was available from so few
countries that it was not included in the common database.
Swedish data for 2008e09, however, demonstrated at 1-year
follow-up a 12% mortality rate, and a 16.1% major limb amputationFigure 1. Median age of patients.rate. 84.2% of patients had improved leg function at 1 year and
64.1% were mobile outdoors without support.
Discussion
Registry data collection is not subject to the rigours of external
validation associated with data collection in randomised trials, and
is often criticised as a result. Nevertheless it does represent real
clinical practice without the selection criteria applied to rando-
mised trials.7 Useful information can be gained from this type of
data and some general conclusions can be legitimately drawn from
the data. Some of the analyses have provided support to the
conclusions of randomised trials and other areas have revealed
differences in outcome that deserve further investigation.
The number of bypasses performed per 100,000 population
varies considerably between countries, being highest in Finland and
lowest in the UK. This may reﬂect the prevalence of peripheral
vascular disease or a variation between countries as to how inter-
mittent claudication is managed. In Finland the proportion of
bypasses done for claudication is low compared to many other
countries and the ﬁgures may also be explained by a very active
management of CLI by infrainguinal bypass. Other factors may also
play a part in this, for example the availability and use of endovas-
cular surgery. In addition in some countries (theUK for example) it is
known that the national database does not capture all cases of
femoropopliteal bypass grafting and the low ﬁgure may represent
under-reporting. Indeed a study of Hospital Episode Statistics in the
UK over a 4-year period between 2002 and 2006 identiﬁed 21,675
femoropopliteal bypasses and 3458 femorodistal bypasses.8 It is not
clear from the literaturewhat constitutes best practice in relation to
thenumberof bypasses that shouldbe expected, the current average
from our data is 10.3 per 100,000 population.Figure 3. Pre-operative risk factors.
Figure 4. Type of graft used for bypass.
Figure 5. Graft type divided according to indication.
Figure 6. Distal anastomosis according to indication.
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Figure 7. Graft type related to site of distal anastomosis for (a) all patients (b) patients with claudication (c) patients with rest pain (d) patients with tissue loss.
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countries with a higher proportion of females in the Scandinavian
countries. Previous studies have shown that between 64% and 98%
of patients undergoing this type of bypass are male.9,10 The
proportion of patients treated for CLI or claudication is an impor-
tant confounding factor when studying gender distribution.
Patients with CLI more often have diabetes and are women than the
claudicants who are more often smokers and men.
The median age of the patients undergoing this type of bypass is
remarkably consistent between countries (overall 70 in men and 76
in women) and is higher than in many previous reports in which
themajority of patients were below the age of 70.9,10 This is likely to
represent an increasingly elderly population across all the coun-
tries. The only exception to this was in Hungary where the patients
were almost ten years younger. This may be due to a high incidence
of smoking in this country and a shorter life expectancy, relativelypoor health education and possibly the overall structure of the
healthcare systems.
The indication for surgical bypass is not uniform across the
countries studied. Overall approximately one quarter of grafts are
performed for claudication. However there is considerable varia-
tionwith the extremes being Denmark (15.7%) and Norway (40.8%).
This information was unfortunately unavailable for Italy which
contributed the highest number of cases overall, although the high
use of synthetic grafts in this country suggests that the majority of
cases may have been done for claudication. The reason for this
variation needs further examination along with examination of the
outcomes in the claudication group. Italy should be encouraged
to collect this data on indication in order to provide it’s surgeons
with meaningful comparative audit. Possible explanations for this
variation include different selection attitudes for bypass surgery
in peripheral arterial disease and also the use of endovascular
Figure 8. (a) Distal anastomosis in infrainguinal bypass for claudication. (b) Distal
anastomosis in infrainguinal bypass for critical ischaemia.
Table 6
Graft patency by graft type (%).
Vein Synthetic Composite
At discharge Claudication 96.5 99.0 95.1
Rest pain 95.4 94.7 90.0
Tissue loss 94.2 94.2 87.6
At 30 days Claudication 95.6 96.5 85.7
Rest pain 92.3 93.5 88.0
Tissue loss 91.2 89.6 75.4
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also indicate a variation in the management of claudication with
some countries favouring a more interventional approach over
conservative management. This Vascunet study did not examine
the use of endovascular treatments, but future international data
comparison might usefully study this.
The recording of pre-operative risk factors is notoriously difﬁ-
cult and this is an area prone to missing data.11 Diabetes is a major
risk factor for peripheral vascular disease and previous studies have
demonstrated a wide variation in the rate of diabetes between
17%10 and 64%.9 In this data there was less variation with most
countries reporting rates between 30% and 47%. Norway reported
a low rate of diabetes of 21.1% perhaps indicating different attitudes
to active intervention for vascular disease in diabetics. As might be
expected hypertension and cardiac disease remain the most
common pre-operative risk factors in these patients, with some
countries reporting hypertension in over 75% of cases. The data also
show a wide variation in current smoking. However it should be
noted that there are differences in the deﬁnition of smoking
between countries which partly explains this variation. ForTable 5
Post-operative complications by indication (%).
Claudication Rest pain Tissue loss
Wound complication 6.3 11.4 12.9
Haemorrhage 2.7 3.5 3.3
Compartment syndrome 0.2 0.9 0.4
Amputation 0.4 2.9 4.7
Acute coronary event 1.7 3.9 5.9
Major stroke 2.3 3.9 1.9
Death 0.5 2.5 4.6example the Swedvasc registry record smoking as smoking within
the previous 5 years.
Patients undergoing peripheral bypass grafting are at risk of
post-operative complications as a result of their pre-existing
comorbidities. The incidence of some of the reported complica-
tions is high with 0.4% of claudicants requiring subsequent ampu-
tation and between 1.7% and 5.9% having an acute coronary event.
In addition it is likely that there is some under-reporting of
complications and therefore these rates may be an underestima-
tion. Therefore the incidence of many of these complications
including wound complications, haemorrhage, perioperative
coronary events and death should be of considerable concern for all
surgeons involved, with a mortality rate approaching 5% for
patients with critical ischaemia and tissue loss.
Although there was a greater use of autologous vein in patients
with critical ischaemia, the use of synthetic grafts varied between
15.7% in Australia and 46.8% in Hungary. A Cochrane review has
demonstrated that there is a clear primary patency beneﬁt of
autologous vein over synthetic grafts for above knee femo-
ropopliteal bypass.12 A further review also demonstrated that the
patency of venous bypasses was superior to PTFE bypasses at all
times and recommended that a venous bypass should always be
chosen if possible.13 In an investigation from the Swedvasc registry
patients operated on for CLI with a bypass to the popliteal artery
above knee had equal results during the ﬁrst year, but then the
curves separated showing only half the patency with PTFE bypass
after ﬁve years.14 The reasons why synthetic grafts were used so
often were not explored in depth in this international comparison,
and therefore the precise reason for this ﬁnding is not clear. In
addition the presence of varicose veins, previous use of the vein for
coronary artery bypass, and unsuitability of the vein were reasons
cited. The data would suggest however that there is potential for
increasing the use of vein over prosthetic bypass in many countries.
Traditionally infrapopliteal bypass is preserved for patients with
critical limb ischaemia, but this study demonstrates that bypasses
are performed to below the knee popliteal artery or a more distal
artery in up to half of all cases done for claudication, and this is true
of all the countries studied. This practice however is supported by
Bryne et al.15 who demonstrated primary and secondary patency
rates of 77% and 81% at 4 years for infrainguinal arterial recon-
struction to the below knee popliteal artery for disabling claudi-
cation. Indeed in some countries such as Denmark infrapoplitealTable 7
Graft patency by country (%).
At discharge Australia Denmark Finland Hungary Norway Switzerland
Claudication 96.8 95.0 100.0 99.4 98.5 97.6
Rest pain 95.0 93.7 99.2 93.7 97.1 93.7
Tissue loss 94.2 92.2 98.6 95.5 97.2 91.3
At 30 days Finland Norway Sweden
Claudication 99.4 94.6 92.2
Rest pain 98.3 94.7 87.5
Tissue loss 96.9 93.0 85.7
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approach to the infrapopliteal artery is considered in that country
to be technically easier and has similar patency to above knee
bypass.
One of the main outcomes of infrainguinal bypass surgery is
graft patency. It is therefore surprising and disappointing that only
a few countries record this as a mandatory outcome ﬁeld. Similarly
most of the countries in this study were not able to provide data on
the incidence of major amputation following lower limb bypass
surgery. Table 6 shows that seven countries make some assessment
of graft patency but only three record graft patency at 30 days. The
Vascunet group recommend that the recording of graft patency at
the veryminimum of 30 days, but ideally for longer, should become
a mandatory requirement for each of the national vascular regis-
tries. Discharge patency rates vary from 91% to 99% in patients with
tissue loss. This graft occlusion rate of up to 9% reinforces the need
to monitor these patients for graft patency prior to hospital
discharge and to record the outcome of this assessment. Sweden
has one of the most robust data collection systems and in this
country 8% of grafts occlude by 30 days in patients with claudica-
tion. This is in keeping with published data; a recent study of
femoropopliteal bypass grafting for occlusive superﬁcial femoral
artery disease and stenting demonstrated a primary patency of 76%
at 12 months for PTFE grafts.16 These ﬁndings need to stimulate
debate about the management and recording of outcomes in this
group of patients internationally.
Limitations of study
This study uses registry data to compare practice between
countries. It is well known that registries have limitations in respect
to the quality and completeness of data and therefore the results of
this study should be considered against this background. It was not
possible, for example to ensure that each country used precisely the
same deﬁnition for all of the variables collected, for example risk
factors such as hypertension. The data presented here represent
data from several countries, but we know that some countries have
a more robust system of data capture than others and in some
countries such as Sweden and Denmark data collection is
compulsory and therefore more complete as a result. Other coun-
tries have voluntary registries and therefore cannot be sure of
complete coverage of all cases, and we know that some of the
registries included were regional. One of the difﬁculties of
comparing infrainguinal bypass surgery between countries is that
we do not know how variation in decision making affects the use of
bypass surgery, and the employment of endovascular techniques
whichmight inﬂuence the use of bypass grafting is not known. This
may act as a confounder in the analysis of some of the data. In
addition to this, whilst some countries have systems for internal
validation of data we have not yet conducted any validation of the
data at an international level. This is the next stage of the process of
international vascular audit and an external international valida-
tion programme is now being undertaken.
In conclusion, we have demonstrated that international vascular
audit is feasible, providing a large volume of data and allowing
thought-provoking international comparisons to be made. With
the fast pace at which vascular surgery is developing, and in
particular the endovascular treatment options, the advantage of
being able to report contemporary data is of particular importance,
and an advantage over randomised and other prospective trials.
This study raises many unanswered questions such as the clinical
impact and outcome of bypass surgery and how this might be
improved, but it is the ﬁrst stage in trying to provide robustevidence of the indications, techniques and outcomes from
infrainguinal bypass across countries. Further work is being
undertaken to ensure that data comparison between countries is
robust, data are complete, and a process for validation of data is put
in place. Recommendations for national registries for stand-
ardisation of key data to allow international comparisons are
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